The putative oncogenic role of WDTC1 in colorectal cancer.
Xiaoyu WangQiuyin CaiJie PingHector Diaz-ZabalaYumin XiaXingyi GuoPublished in: Carcinogenesis (2022)
Microsatellite instability (MSI) is detected in approximately 15% of colorectal cancers (CRCs). WD40 and tetratricopeptide repeats 1 (WDTC1) is frequently mutated in MSI CRC, indicating that it may contribute to CRC development. However, the functional evidence of the role of WDTC1 in CRC development remains unknown. Herein, we conducted in vitro assays to examine the function of WDTC1 using knockdown experiments in three CRC cell lines, SW480, CACO2, and LoVo. We provided strong evidence that silencing WDTC1 significantly suppressed cell proliferation, migration, and invasion consistently in all three CRC cell lines. To evaluate the potential role of WDTC1 in regulating CRC-related genes, we conducted RNA sequencing after 24 and 48 h in SW480 cells after treating WDTC1-siRNA and its vehicle control cells. Differential gene expression analysis identified 44 (42 downregulated and 2 upregulated) and 16 (all downregulated) genes, at time points of 24 and 48 h, respectively, whereas 15 downregulated genes were commonly detected at both time points. The ingenuity pathways analysis suggested that the most significant enrichments associated with cancer function and upstream regulator ATM/ATR were observed for these commonly observed genes. We further verified differential gene expression of eight cancer-related genes, ARHGEF12, GSTP1, FNDC3A, TMTC3, RTN4, RRM2, UHMK1, and PTPRF, using RT-PCR in all three cell lines. Our findings provided additional insight into the oncogenic role of WDTC1 in CRC development.
Keyphrases
- genome wide identification
- genome wide
- induced apoptosis
- gene expression
- transcription factor
- cell proliferation
- papillary thyroid
- cell cycle arrest
- dna methylation
- bioinformatics analysis
- squamous cell
- genome wide analysis
- dna damage
- dna damage response
- oxidative stress
- high throughput
- dna repair
- cell cycle
- single cell
- cancer therapy
- childhood cancer
- drug delivery
- hyaluronic acid